Jenna Whitehead
Nurse Practitioner · Marion, ILNPI 1891452439
Payments from drug & device makers
Across 253 payments — averaging $17.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$721
- AstraZeneca$713
- Amgen$489
- AbbVie$452
- Biohaven Pharmaceutical Holding Company Ltd.$251
- Optinose US, Inc.$235
- plus $1K from 22 others
What the payments were for
- Food & beverage$4,334100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 45 | $721 |
| AstraZeneca | 32 | $713 |
| Amgen | 31 | $489 |
| AbbVie | 33 | $452 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $251 |
| Optinose US, Inc. | 12 | $235 |
| Dexcom, Inc. | 17 | $219 |
| Pfizer | 12 | $197 |
| Novo Nordisk | 11 | $188 |
| Abbott | 7 | $118 |
| GSK | 7 | $108 |
| Exact Sciences | 6 | $99 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $86 |
| Sumitomo Pharma America, Inc. | 4 | $83 |
| Boehringer Ingelheim | 5 | $81 |
| Merck | 3 | $52 |
| Sunovion Pharmaceuticals Inc. | 2 | $33 |
| Mylan Specialty L.p. | 2 | $31 |
| Sanofi Pasteur Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Bioxcel Therapeutics, Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Organon | 1 | $16 |
| Nestle Healthcare Nutrition Inc. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,334 in reported general payments places this provider in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 66 | $76,071 |
| JardianceEmpagliflozin | 58 | $67,705 |
| TrulicityDulaglutide | 42 | $57,306 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 81 | $57,242 |
| MounjaroTirzepatide | 41 | $55,268 |
| OzempicSemaglutide | 47 | $54,739 |
| Repatha SureclickEvolocumab | 54 | $54,090 |
| FarxigaDapagliflozin Propanediol | 52 | $47,366 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 42 | $32,712 |
| XareltoRivaroxaban | 28 | $29,725 |
| GemtesaVibegron | 16 | $17,889 |
| LinzessLinaclotide | 13 | $7,839 |
| MyrbetriqMirabegron | 12 | $6,999 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $3,518 |
| Atorvastatin Calcium | 288 | $3,004 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $721 | $112,57483 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $713 | $80,07894 claims |
| PfizerEliquis | $197 | $76,07166 claims |
| Boehringer IngelheimJardiance | $81 | $67,70558 claims |
| GSKTrelegy Ellipta | $108 | $57,24281 claims |
| Novo NordiskOzempic | $188 | $54,73947 claims |
| Johnson & JohnsonXarelto | $16 | $29,72528 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $83 | $17,88916 claims |
| AbbVieLinzess, Synthroid | $452 | $9,30137 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Other nurse practitioner in Marion
- Robin DaileyMarion$14K
- Erika VuckoChicago$417K
- Deepa VallikatWest Dundee$332K
- Maria MalotoNaperville$135K
- Valerie LaroyOak Lawn$112K
- Jennifer LiebChampaign$109K
- Tanya MungerRockford$106K
- Kristy LukeChicago$77K
- Yvonna OldakerFlossmoor$74K
- Heather PiercePekin$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.